Cargando…

Major Changes of von Willebrand Factor Multimer Distribution in Cirrhotic Patients with Stable Disease or Acute Decompensation

Background There is an unstable balance between pro- and anti-haemostatic processes in patients with cirrhosis. We hypothesized, that in patients with acute decompensation (AD) the major alterations of von Willebrand factor (VWF) could contribute to the pro-thrombotic situation as compared to patie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Palyu, Eszter, Harsfalvi, Jolan, Tornai, Tamas, Papp, Maria, Udvardy, Miklos, Szekeres-Csiki, Katalin, Pataki, Lajos, Vanhoorelbeke, Karen, Feys, Hendrik B., Deckmyn, Hans, Tornai, Istvan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Georg Thieme Verlag KG 2018
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6202934/ https://www.ncbi.nlm.nih.gov/pubmed/29972862 http://dx.doi.org/10.1055/s-0038-1661393

Ejemplares similares

Structural hierarchy of mechanical extensibility in human von Willebrand factor multimers
por: Csányi, Mária Csilla, et al.
Publicado: (2023)

Abnormal ferritin levels predict development of poor outcomes in cirrhotic outpatients: a cohort study
por: Tornai, David, et al.
Publicado: (2021)

Evaluation of a semi‐automated von Willebrand factor multimer assay, the Hydragel 5 von Willebrand multimer, by two European Centers
por: Bowyer, Annette E., et al.
Publicado: (2018)

Establishing reference intervals for von Willebrand factor multimers
por: Pikta, Marika, et al.
Publicado: (2022)

The Value of Neutrophil-to-Lymphocyte Ratio to Identify Bacterial Infection and Predict Short-Term Mortality in Patients with Acutely Decompensated Cirrhosis
por: Janka, Tamás, et al.
Publicado: (2023)

Improving diagnosis of von Willebrand disease: Reference ranges for von Willebrand factor multimer distribution
por: Vangenechten, Inge, et al.
Publicado: (2020)

Update on von Willebrand factor multimers: focus on high-molecular-weight multimers and their role in hemostasis
por: Stockschlaeder, Marcus, et al.
Publicado: (2014)

Gut barrier failure biomarkers are associated with poor disease outcome in patients with primary sclerosing cholangitis
por: Tornai, Tamas, et al.
Publicado: (2017)

Control of Von Willebrand Factor Multimer Size by Thrombospondin-1
por: Xie, Lijuan, et al.
Publicado: (2001)

A novel von Willebrand factor multimer ratio as marker of disease activity in thrombotic thrombocytopenic purpura
por: Falter, Tanja, et al.
Publicado: (2023)

Differences in von Willebrand factor function in type 2A von Willebrand disease and left ventricular assist device‐induced acquired von Willebrand syndrome
por: Deconinck, Shannen, et al.
Publicado: (2018)

Von Willebrand Factor Multimer Densitometric Analysis: Validation of the Clinical Accuracy and Clinical Implications in Von Willebrand Disease
por: Boender, Johan, et al.
Publicado: (2021)

Structure and Function of Recombinant versus Plasma-Derived von Willebrand Factor and Impact on Multimer Pharmacokinetics in von Willebrand Disease
por: Gritsch, Herbert, et al.
Publicado: (2022)

Characterization of Von Willebrand Factor Multimer Structure in Patients With Severe Aortic Stenosis
por: Kellermair, Joerg, et al.
Publicado: (2017)

Advancing multimer analysis of von Willebrand factor by single-molecule AFM imaging
por: Löf, Achim, et al.
Publicado: (2019)

Von Willebrand Factor Multimers and the Relaxation Response: A One-Year Study
por: Dal Lin, Carlo, et al.
Publicado: (2021)

Multimer Analysis of Von Willebrand Factor in Von Willebrand Disease with a Hydrasys Semi-Automatic Analyzer—Single-Center Experience
por: Skornova, Ingrid, et al.
Publicado: (2021)

Presepsin teardown - pitfalls of biomarkers in the diagnosis and prognosis of bacterial infection in cirrhosis
por: Papp, Maria, et al.
Publicado: (2016)

Von Willebrand factor multimer quantitation for assessment of cardiac lesion severity and bleeding risk
por: Austin, Christopher O., et al.
Publicado: (2017)

High circulating osteoprotegerin levels are associated with non-zero blood groups
por: Nagy, Elod Erno, et al.
Publicado: (2016)

von Willebrand factor deficiency does not influence angiotensin II-induced abdominal aortic aneurysm formation in mice
por: Portier, Irina, et al.
Publicado: (2018)

Inhibition of disulfide bonding of von Willebrand protein by monensin results in small, functionally defective multimers
Publicado: (1985)

Commonly used anti–von Willebrand factor antibody for multimer analysis cross‐reacts with fibronectin, which is difficult to distinguish from von Willebrand factor
por: Eura, Yuka, et al.
Publicado: (2021)

The von Willebrand factor A1 domain mediates thromboinflammation, aggravating ischemic stroke outcome in mice
por: Denorme, Frederik, et al.
Publicado: (2020)

von Willebrand factor in experimental malaria‐associated acute respiratory distress syndrome
por: Kraisin, Sirima, et al.
Publicado: (2019)

ADAMTS 13 deficiency is associated with abnormal distribution of von Willebrand factor multimers in patients with COVID-19
por: Pascreau, Tiffany, et al.
Publicado: (2021)

Severe Plasmodium falciparum Malaria Is Associated with Circulating Ultra-Large von Willebrand Multimers and ADAMTS13 Inhibition
por: Larkin, Deirdre, et al.
Publicado: (2009)

Evaluation of a new semi-automated Hydragel 11 von Willebrand factor multimers assay kit for routine use
por: Pikta, Marika, et al.
Publicado: (2021)

Transient elastography and von Willebrand factor as predictors of portal hypertension and decompensation in children
por: Goel, Akshat, et al.
Publicado: (2023)

Type 2B von Willebrand disease with or without large multimers: A distinction of the two sides of the disorder is long overdue
por: Casonato, Alessandra, et al.
Publicado: (2017)

Circulating Von Willebrand factor and high molecular weight multimers as markers of endothelial injury predict COVID-19 in-hospital mortality
por: Philippe, Aurélien, et al.
Publicado: (2021)

von Willebrand Factor and Platelet Glycoprotein Ib: A Thromboinflammatory Axis in Stroke
por: Denorme, Frederik, et al.
Publicado: (2019)

Serological biomarkers for management of primary sclerosing cholangitis
por: Tornai, David, et al.
Publicado: (2022)

Loss of tolerance to gut immunity protein, glycoprotein 2 (GP2) is associated with progressive disease course in primary sclerosing cholangitis
por: Tornai, Tamas, et al.
Publicado: (2018)

Impact of intraoperative use of venovenous extracorporeal membrane oxygenation on the status of von Willebrand factor large multimers during single lung transplantation
por: Oishi, Hisashi, et al.
Publicado: (2023)

Emerging medical therapies for severe alcoholic hepatitis
por: Tornai, David, et al.
Publicado: (2020)

Rapid Restoration of Thrombus Formation and High-Molecular-Weight von Willebrand Factor Multimers in Patients with Severe Aortic Stenosis After Valve Replacement
por: Yamashita, Keigo, et al.
Publicado: (2016)

Cryptic non-canonical splice site activation is part of the mechanism that abolishes multimer organization in the c.2269_2270del von Willebrand factor
por: Daidone, Viviana, et al.
Publicado: (2020)

Letter in response to: circulating von Willebrand factor and high molecular weight multimers as markers of endothelial injury predict COVID-19 in-hospital mortality
por: Bhogal, P., et al.
Publicado: (2021)

Antiviral Therapy in HCV-infected Decompensated Cirrhotics
por: Danish, Fazal A., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_0gv86j58feaqle8irqk9vddhed